In this trial, a retrovirus was used to transport normal adenosine deaminase (ADA) genes to T cells isolated from patients, which were then reinfused into the patient’s body to treat children with ADA-deficient severe combined immunodeficiency disease (ADA-SCID) [117]. The gene discussed is ADA; the disease is severe combined immunodeficiency.